The 1989 IDSA's Journal, "Reviews of Infectious Diseases" Special
Supplement 6, September-October, on Lyme and Spirochetal Diseases.
On this page is some of the
data the Lyme crooks (Yale/ NYMC/ ALDF/ IDSA/ Kaiser
cabal) refused to turn over to the Connecticut Attorney General for
a year and a half before
settling out
of court.
This chapter is to include what was known about "Lyme Disease" up until
the establishment of the RICO gang at New York Medical College in 1990 with
Kaiser-Permanente. The subsequent chapter on Biomarkers is meant to flesh out the
truth about the seriousness of Lyme disease and OspA vaccination as both
reported but suppressed by this Lyme Mafia and how that
negatively affected people with other very serious diseases.
1989 IDSA REVIEWS, FILE LIST:
http://www.actionlyme.org/IDSA_GREATIMITATOR.htm (neurologic disease
Imitator, primarily)
http://www.actionlyme.org/IDSA_IMMUNO_DATTWYLER.htm (Discusses
treatment failure and neonatal Lyme)
http://www.actionlyme.org/IDSA_CLINIPATH_DURAY.htm ("Epstein-Barr-like transformed B
cells")
http://www.actionlyme.org/IDSA_JOHNSONCULTURING.htm (reversion
from spheroplast takes months and not weeks; see
Klempner's "bogus article")
http://www.actionlyme.org/IDSA_TMTFAILS.htm (treatment fails in half the
cases, says Sigal, Steere, Dattwyler and Luft)
http://www.actionlyme.org/IDSA_TMTSYPHILIS.htm (treatment endpoint
unknown)
http://www.actionlyme.org/IDSA_HALPERINNEURO.htm (these neurologic diseases do
not test CDC Dearborn-positive)
http://www.actionlyme.org/ID_REVIEWS_SCHMID.htm (CDC officer
Schmid says Lyme
like other spirochetal diseases; treatment unknown)
http://www.actionlyme.org/LYME_AND_LUPUS_STEERE.htm Lyme and
Lupus, by Allen Steere, and the reason Yale owned a Lyme and Lupus Clinic, now
called L2-Diagnostics.
EARLY_CNS_INVASION.htm Benach - spirochetes
invade the brain right away.
Dattwyler_Luft_Bb_DNA_in_CSF.htm
1994 FDA Meeting, Dattwyler and Luft talking about early CNS invasion of
spirochetes, and then of course, they're
permanent.
Dattwyler saying Bb invades the brain early:
http://www.ncbi.nlm.nih.gov/pubmed/1740859
LINK to PubMed, All, IDSA's 1989 "Special Supplement on Lyme"
http://www.actionlyme.org/ALSLYME47.htm (47% association between ALS and
Borreliosis, says JJ Halperin; these cases will not test Dearborn-positive,
which is a homicide charge)
http://www.actionlyme,org/BARBOUR_MUTANTS_1992.htm
(antibodies exert "selection pressure," or all the Osps mutate, or,
"Lyme is actually Relapsing Fever" and therefore vaccines won't prevent it.)
http://www.actionlyme.org/Congenital_Brain_Infection_of_Newborn_Resulting_in_Death.htm (4 reports by
Steere and Yale)
http://www.actionlyme.org/Duray, 1992, Cold Spring Harbor ("Epstein-Barr-like
transformed Chronic Lyme white blood cells")
http://www.actionlyme.org/CHRONIC_NEUROLOGIC_LYME_STEERE.htm ," by Allen Steere
CROOKS REFERENCE
(refer to) VIABILITY OF THE CYST FORM REPORTS:
http://wwwactionlyme.org/IDSA_CYST_VIABLE.htm
http://www.actionlyme.org/BURGDORFER_CYST.htm
http://www.actionlyme.org/RICOCHRON.htm
RICO chronology, CDC instructs how to weaponize your Borrelia, 1964

←This disease described by JJ Halperin - now known as "fibromyalgia" which is
officially, catastrophizing - is not detectable via the Dearborn/Steere method.
Neurologic abnormalities, seen in 11% of the cases (7) while ECM is still
present or 1 to 6 months later, include aseptic meningitis [not detected by
Mark Klempner in his 4.7 million dollar Femzalgia
study, since he looked for extra white blood cells in the spinal fluid of his
victims, of course knowing full-well what he was doing, criminally]
encephalitis [now denied completely by Mark Klempner], choria, cerebellar
ataxia, cranial neuritis, motor and sensory radiculitis, mononeuritic multiplex,
the Guillain-Barre syndrome, and myelitis (2,8). Encephalitis is usually
mild, with somnolence, emotional liability, depression, impaired memory and
concentration, and behavioral changes accompanied by EEG abnormalities.
Recovery may be incomplete (2).
"Lyme
borreliosis-associated encephalopathy"-- JJ Halperin

====================================
LINK TO MEDLINE, ALL, "REVIEWS OF INFECTIOUS DISEASES,"
(the former name of the IDSA journal) 1989 Supplement; The status summary
that lead to the creation of the ALDF.com cabal at New York Medical College and
Kaiser-Permanente's takeover of "Lyme Disease"


Title page
Now we're really going to see some
self-ass-biting.
A-hem.
BACKGROUND
1989 came after 1988, which was the Year of Lyme
as a cause of Lower Motor Neuron Disease (ALS-like)
and the
Year of
the Congenital Lyme Autopsy by Yale University and others, including Paul
Duray, perhaps the world's top pathologist. Paul Duray happens to be on
the side of truth, which is Camp C, which is us, ActionLyme, the Greater
Hartford Lyme Group, and the LymeCryme.com team. Paul Duray works for
everybody. He works for the National Cancer Institute. He works for the
Army, Ft. Detrick.
Scared yet? You better be, because the
National Cancer Institute is sort of in Ft. Detrick. Ya wanna be more
scared? Duray worked with the famous Steven Hatfill - anthrax-mailer
false-accusee - with NASA rotating tissue bioreactors (centrifugal force
recreates gravity in zero-gravity) and guess what they found?
Spirochetes grow "exponentially" in human brain
tissue in that NASA bioreactor bath.
Not only do viruses cause cancer and hang out
with the US Army at Ft. Detrick, and not only are spirochetes more than happy to
be doubly-rotating in human brain cells, but Paul Duray discovered that, "Hmmm.
These chronic Lyme victims' lymphocytes look like Epstein-Barr virus transformed
or mutated cells."

Epstein-Barr transformed cells are quite
interesting because these researchers like to use them due to the effect of
Epstein-Barr on IMMORTALIZING cells. That is, cells infected with
Epstein-Barr somehow don't commit suicide upon the usual cues that non-EB
infected cells do.
[The non-committal of suicide by infected
cells is a problem for chronic Lyme and LYMErix Disease®. The disease
itself, LYMErix Disease, I am trademarking since I am the one who organized
the national campaign to get adverse events victims reported to the FDA, and
then I explained exactly what happened with the LYMErix fraud, in scientific
terms, to the FDA Vaccine Committee in January '01. I think I will also be trademarking, um,
Plum Island
Slyme Disease® as that will refer to all the stealth disablers that
harbor immune suppressing antigens.]
"Does Bb reactivate latent virus infections in
tissues?"
Should we follow up on that?
Chugging along under this country's huge burden
of neglect and abuse, crime, and dereliction of duty, I, myself tabulated the
perfectly logical five years ago, but naturally no one understood it, adopted
it, used it, came up with it logically on their own, nor do I think they
understand it still:
Pathologies_indices.htm
What are the known syndromes associated with
Lyme and what are the markers of them found out of range?
Then you create your laboratory around the tests
you know need to be run.
And the Biomarkers contain the methods for how to detect the out-of-range
markers.
It's SIMPLE!
Some of the BioMarkers
found in Lyme are
Matrix-metalloproteinases in the spinal
fluid, glial fibrillary acidic protein
in the spinal fluid (degradation of glial cells, or the energy-producing cells
in the brain), QEEG abnormalities,
autoantibodies, dysregulated
interleukens (cytokines) in the blood,
anti-heat shock proteins are
hypothetically involved in
neuroborreliosis, dysregulated monoamines (misuse of precursors to
neurotransmitters, dysregulated neurotransmitters due to cytokines etc acting as
neurotransmitters),
anti-flagellin antibodies (Alan
Barbour stated in a patent that this was
the reason 41-kD or flagellin should not
be used as a vaccine- they think anti-41 antibodies attach to neurons), blood-brain
barrier abnormalities (decreased
perfusion or blood flow to the brain, as
demonstrated in SPECT imaging), abnormal PET scan
or brain metabolism deficits, which may
be the most significant marker patients need to end the harassment.
See
also: BIOMARKERS
DISORDER
Marker |
LYME |
MS |
CFIDS |
FM |
ALS |
LUPUS |
GUILLAIN-BARRE |
BANNWARTH'S |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Glial Fibrillary Acid Protein |
X |
X |
ND |
ND |
X |
X |
X |
ND |
Matrix-Metalloproteinase |
X |
X |
ND |
X |
X |
X |
X |
ND |
Quinolinic
Acid |
X |
X |
ND |
ND |
X |
X |
ND |
ND |
T Cells |
StEeRe |
Diff/Dx? |
X |
X |
n/a |
X |
X |
X |
CSF T Cells |
X |
given |
? |
ND |
X |
X |
X |
ND |
Antisulfatides |
ND |
X |
ND |
ND |
X |
X |
ND |
ND |
Antigangliosides |
X |
X |
ND |
ND |
X |
X |
X |
ND |
Pterins |
X |
X |
X |
X |
X |
X |
X |
ND |
Anti-Heat Shock |
X |
X |
X |
ND |
X |
X |
X |
ND |
PET |
|
|
|
|
|
|
|
|
SPECT |
X |
X |
|
|
|
|
|
|
EEG |
X |
X |
|
|
|
|
|
|
EMG |
|
|
|
|
|
|
|
|
Antiphospholipids
|
yes |
|
|
|
|
obviously |
|
|
|
|
|
|
|
|
|
|
|
IL-1a |
|
|
|
|
|
|
|
|
IL-1b |
|
|
|
|
|
|
|
|
IL-2 |
|
|
|
|
|
|
|
|
IL-4 |
|
|
|
|
|
|
|
|
IL-6 |
|
|
|
|
X |
|
|
|
IL-8 |
|
|
|
|
|
|
|
|
IL-10 |
|
|
|
|
|
|
|
|
Haplotypes |
same for MS |
|
|
|
X |
same for MS |
X |
ND |
Etc.
And, working with them (Kaiser
literally is based, still, at New York Medical College in Valhalla, NY), just
like the oil bankers thought they know what's best for America (fake wars and
fake terrorists who happen to live right near the oil and nevermind
the tearrists in East Timor or Rwanda or any other place we have to watch some
punk-ass Pol Pot-wannabe play machete-king of the jungle with their
rape-crusaders leaving in their wake the terms of endearment for the next
generation's do-over), Kaiser-Permanente thinks they know what's best for
America. And just like the messy non-result we got in Iraq and Afghanistan
and the resultant no allies, and Russia saying "things are worse now than they
were during the Cold War" (Russian Federation Foreign Minister Sergei Lavrov,
June 20, 2008), these idiots got a lawsuit and an international reputation for
being "STUPID and INCOHERENT," in addition to being passed over for one billion
dollars in research grants, just because everyone finally has had
enough of their outrageous "LYMErix is the first ever placebo vaccine for
Yuppie fake diseases" claims and want some real answers now.
These are not to mention how far and wide
Lyme has spread because they lied about the vaccines and did not tell us
that "RELAPSING FEVER means NO VACCINES ARE EVEN POSSIBLE."
We sufferers of this disease could hardly
argue that that wasn't the worst result, despite for years not
being believed even by those close to us and wishing this disease on those
non-believers as the best medicine for such arrogant pukes.
No one can undo it. It's permanent.
It's a Trojan Horse for those who think they're better now.
So, what is not clear? How do we start to
unscramble this nonsense?
The IDSA Reviews gave us lots of data on, well,
the relatedness between the most prominent spirochetal diseases in America,
anyway, Syphilis and Borreliosis. They told us that re-culturing
spirochetes could take months and not weeks in BSK media. They told us
that Lyme damages the brain and nerves directly. They told us the
treatment failed in half the cases and that the treatment endpoint was yet
unknown. And they told us we'd better WORRY about congenital
Lyme.
They told us what we already knew because we
HAVE this disease and we know how serious it is.
Borreliosis is worse than Syphilis times two.
FROM the 1989 IDSA REVIEWS, Special
Supplement on Lyme and spirochetal diseases:
RUSSELL JOHNSON, CULTURING -
Says Russell Johnson, spheroplasts could take months to revert to intact spirochetes in BSK
media. Have the crooks done this is recent history (KLEMPNER)??
Of course not. Facts and truth were never part of the ALDF (Kaiser and
the Patenteers) equation.
What do they look like in the
meanwhile?
Hooo-boy, that's something you really
have to look around for to see with your own eyeballs:
(PLUM ISLAND SLYME, humorously discussed by the Russian scientists associated
with New York Medical College, somehow).
Willy Burgdorfer on spheroplasts/spheroblasts
And from one of the real pukes of medicine,
Jorge Benach (who will really regret his comment that we Lyme victims are
stupid, but that "Allen Steere has the science on his side," in a Letter to
the Editor of the New York Times).

Cute??
NEW "GREAT IMITATOR," PACHNER
The causative agent of Lyme disease,
Borrelia burgdorferi, is a highly neurotropic organism that not only can
produce symptomatic neurologic disease but also can exist dormant within the
central nervous system (CNS) for long periods. Two distinct types of
neuroborreliosis occur at different stages of Lyme disease. Second-stage
Lyme meningitis resembles aseptic meningitis and is often associated with
facial palsies, peripheral nerve involvement, and/or radiculopathies. Lyme
meningitis may be the first evidence of Lyme disease, occurring without a
history of erythema chronicum migrans or flu-like illness. Third-stage
parenchymal involvement causes a multitude of nonspecific CNS manifestations
that can be confused with conditions such as multiple sclerosis, brain
tumor, and psychiatric derangements. Manifestations of CNS parenchymal
involvement in Lyme disease are generally associated, however, with a
history of erythema chronicum migrans, meningitis, or carditis. Both second-
and third-stage Lyme neuroborrelioses are commonly misdiagnosed because they
are relatively uncommon and because they mimic many better-known disorders.
DURAY, CLINICAL PATHOLOGICAL CORRELATES
The multisystem effects caused by
Borrelia burgdorferi in Lyme disease are multiple, varied, and
unpredictable. In some patients, the full extent of the infection consists
of a stage I acute systemic viral-like illness. Stage II primarily involves
the cardiovascular system (myocarditis) and/or the central nervous system
(CNS) (meningoencephalitis, polyradiculitis). More inflammatory cells are
found in the heart and nervous system structures during this intermediate
stage than are found in any tissues involved during stage I. Stage III is
characterized by peripheral neuropathy and CNS disorders such as dementia or
transverse myelitis and arthritis and synovitis of large joints such as the
knee. Chronic Lyme disease is also associated with multiple and seemingly
unrelated cutaneous manifestations such as acrodermatitis chronica
atrophicans, sclerodermoid-like reactions, lichen sclerosus et atrophicus,
subcuticular fibrous nodules, eosinophilic fasciitis-like lesions of the
extremities, and, possibly, granuloma annulare. With care, spirochetes can
be recovered or demonstrated by silver staining in most of the above
lesions. Spirochetes have yet to be seen in the tissues of autonomic ganglia
or peripheral nerves.
But by 2000, the monkey autopsies had been
performed (this entire website was given in full-text hard-copy to James
Phillips, a Yale perjuring malpractitioning sex-pervert):
http://www.geocities.com/kmdickson0308/lyme-dilemma.html
http://www.geocities.com/kmdickson0308/3-17.txt
"Nerve changes. A detailed survey
of the central nervous system lesions was carried out, which included 50
sampling sites. The lesions observed are listed in Table 4.
Sensory ganglia of the dorsal root and trigeminal ganglia of animals J 831
and K 216 had individual neurons that immunostained positive with anti-Bb
7.5kD lipoprotein mAb (fig 16). These neurons were swollen and were
undergoing chromatolysis. The dorsal root ganglia of the thoracic and
cervical regions were especially affected. Nerve sheath fibrosis
within the spinal cord was limited to the thoracic segment in animal J 831.
Positive staining with anti-Bb mAb, accompanied by vacuolization of
peripheral nerves, was observed in three of four animals. This change
occurred as a radiculoneuropathy of the thoracic segment and peripheral
nerves (Fig 17). Animal L 131 had five peripheral nerves affected.
When the same nerves were stained for fat, focal vacuolization was observed
(Figs 18 and 19). Focal demyelination of the cervical cord was limited
to J 831. Lymphocyte infiltration of the affected nerves was mild in
extent and confined to perivascular spaces. In animals L 131 and K 383, Bb
could be demonstrated by immunostaining (Fig 20).
" The pathogenesis of Lyme disease neuropathies is poorly
understood...Sensory ganglia involvement has previously been described in
human borreliosis (27-28). In our study, many of the ganglia positive for Bb
by immunstaining were undergoing necrosis. This staining was seen in
two out of five animals and was not accompanied by a cellular infiltrate.
" Nerve tissues with perivascular lymphocyte infiltrate were present in
three out of five animals. This was the only lesions where
extracellular Bb could be demonstrated. Peripheral cutaneous nerves were
prominantly affected in the early phase of borreliosis of rhesus
macaques(20, 28-29). Changes of the nervous system include the full range of
changes observed in neuroborreliosis, which suggests a variety of disease
mechanisms, including sensitization or mimicry as suggested by the
vacuolization of peripheral nerves and cytokine-mediated destruction of
nerves as a result of the infiltrating lymphocytes..."
The point of giving MDs scientific medical
data would be for them to read it and learn about it. It is not meant
to be toilet paper or fodder for the diagnosis of "Unibomber Chemist," or
"dangerously intelligent." It is meant to be read and acquired as
knowledge for the intrinsic value of knowledge itself- which is protection
of oneself and others from FRAUD or a lie.
ABNORMALITIES OF THE NERVOUS SYSTEM, HALPERIN
Objective measures of neurologic function
were used to assess response to treatment in patients with late Lyme
borreliosis. Neurophysiologic evidence of peripheral neuropathy was present
in 64 of 137 patients tested. Measures of distal axon function (sensory
amplitude and conduction velocity, motor terminal latency) were most
affected. Repeat studies following 60 patients receiving antimicrobial
therapy demonstrated significant improvement in these values. Before and
after therapy 17 patients with late Lyme borreliosis and prominent
subjective cognitive dysfunction underwent neuropsychologic tests of memory,
conceptual ability, concentration, psychomotor function, overlearned
intellectual abilities, and mood. Significant abnormalities were evident
before treatment; all reversed with antimicrobial therapy. Many patients
with this encephalopathy had specific abnormalities revealed by magnetic
resonance imaging of the brain and had evidence of intrathecal synthesis of
antibody to Borrelia. These findings indicate that late Lyme borreliosis
commonly causes nervous system abnormalities that are reversible with
appropriate antibiotic therapy.
As we now know (more recently from
Brian Fallon
at Columbia and I know, myself,
from personal experience) these patients tend to
relapse, but more importantly, Mark Klempner reported that there is no such
thing as cognitive compromise in Lyme victims.
You can get psychiatrists to say anything, as
previously mentioned:
University of
Connecticut School of Medicine, Farmington, USA. kaplan@psychiatry.uchc.edu
BACKGROUND: It is
controversial whether additional antibiotic treatment will improve cognitive
function in patients with post-treatment chronic Lyme disease (PTCLD).
OBJECTIVE: To determine whether antibiotic therapy improves cognitive
function in two randomized double-blind placebo-controlled studies of
patients with PTCLD. METHODS: A total of 129 patients with a
physician-documented history of Lyme disease from three study sites in the
northeast United States were studied. Seventy-eight were seropositive for
IgG antibodies against Borrelia burgdorferi, and 51 were seronegative.
Patients in each group were randomly assigned to receive IV ceftriaxone 2 g
daily for 30 days followed by oral doxycycline 200 mg daily for 60 days or
matching IV and oral placebos. Assessments were made at 90 and 180 days
after treatment. Symptom severity was measured from the cognitive
functioning, pain, and role functioning scales of the Medical Outcomes Study
(MOS). Memory, attention, and executive functioning were assessed using
objective tests. Mood was assessed using the Beck Depression Inventory and
Minnesota Multiphasic Personality Inventory. RESULTS: There were no
significant baseline differences between seropositive and seronegative
groups. Both groups reported a high frequency of MOS symptoms, depression,
and somatic complaints but had normal baseline neuropsychological test
scores. The combined groups showed significant decreases in MOS symptoms,
higher objective test scores, and improved mood between baseline and 90
days. However, there were no significant differences between those receiving
antibiotics and placebo. CONCLUSION: Patients with post-treatment chronic
Lyme disease who have symptoms but show no evidence of persisting Borrelia
infection do not show objective evidence of cognitive impairment. Additional
antibiotic therapy was not more beneficial than administering placebo.
So, there you have it. "Lyme is an
imaginary disease prevented by the placebo vaccine, LYMErix," says Mark
Klempner, now the head
of a CDC bioweapons level IV lab in Boston.
DATTWYLER and LUFT, "Treatment fails in half the
cases and we better be worried
about pregnant women with Lyme."
DATTWYLER and LUFT,
IMMUNOLOGICAL ASPECTS
Immune responses to Borrelia burgdorferi
infection are now well characterized. Following infection there is an early
T cell response and a more slowly evolving B cell response. IgM antibodies
appear first and are followed by IgG and IgA. Early antibodies are
primarily against a 41-kilodalton flagellum-associated antigen;
responses to other spirochetal antigens develop later. Serologic assays that
use whole B. burgdorferi preparations are not always able to detect an early
rise in antibodies above a background of crossreactive antibodies present in
most uninfected individuals. Moreover, some individuals with neurologic
involvement who lack diagnostic levels of serum antibody to B. burgdorferi
have high levels of the antibody in their cerebrospinal fluid. Specific T
cell blastogenesis [used by Allen Steere to diagnose inhaled
spirochetes in his lab workers] to B. burgdorferi can further document
infection. Analysis of T cell subsets in Lyme arthritis demonstrates a
marked decrease in the CD4+2H4+ subpopulation in the synovial fluid,
although normal numbers of these cells are present in peripheral blood.
Immunologic measurements are useful in evaluating and treating a wide array
of patients who may be infected with B. burgdorferi.
TMT of SYPHILIS, CEF RECOMMENDED, ENDPOINT UNKNOWN
"Recent
evaluations of ceftriaxone for early syphilis therapy are promising; however,
the optimal dose and duration of therapy are unknown."
CDC's GEORGE SCHMID on LYME and SYPHILIS'
SIMILARITIES OOohh, Aahh, ya think?
RELATED and reported at around that
time:
ALS and Lyme - by JJ Halperin and Ray Dattwyler, authors
of the new and bogus IDSA Guidelines.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=2334308&query_hl=24&itool=pubmed_docsum
"Of 19 unselected patients with the diagnosis of amyotrophic lateral
sclerosis (ALS) living in Suffolk County, New York (an area of high Lyme disease
prevalence), 9 had serologic evidence of exposure to Borrelia burgdorferi."
47%; 9 of 19 men with Lou Gehrig's Disease in a Lyme-endemic area were exposed to
borrelia
Bb INFECTION OF THE BRAIN (plasmid changes)-
PACHNER, 1990
"EARLY CENTRAL NERVOUS SYSTEM INVASION"-
BENACH
Roland Martin's former
NINDS-MS homepage (he
went home to Germany)
Oligoclonal bands in
the CFS of Lyme victims (and MS,
again, by NINDS' former Roland Martin who went home to Germany because he did
not prove Lyme is a cause of MS as an autoimmune T cells disease, just like Steere did
not prove Lyme is an T cell autoimmune disease) The usefulness of the
Roland Martin reports is that they refute Steere's notion that Lyme is just a
bad knee.
Roland Martin's Autoreactive BRAIN and NERVE T cells in the spinal fluid of Lyme Borreliosis.
This mechanism of pathology really has not been proven. There does not
seem to be any real T cell autoimmunity going on, here, in Lyme/MS, as least as
a process researchers can re-create in a lab.
STEERE and LUPUS
STEERE, BENACH and ANTIGANGLIOSIDE
ANTIBODIES
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17045505
NEW, CDC says-- "Human infection by
Borrelia burgdorferi, the etiological agent for Lyme disease, can result in
serious acute and late-term disorders including neuroborreliosis, a degenerative
condition of the peripheral and central nervous systems." -
THIS KIND OF LYME IS UNDETECTABLE WITH CDC'S CURRENT TESTING STANDARD, AND
THE CDC KNOWS IT.
Direct destruction of nerve and brain cells, Benach
by Jorge Benach, who sent a letter to the editor of the New York Times
stating that Allen Steere was right, that no one had Lyme disease, and that the
people who claimed that they did (that they did not have the imaginary Allen
Steere in Europe kind of imaginary self-limiting autoimmune knees disease), were
crazy, and that Steere was right and "has the science on his side," when
Steere had said that we don't have a chronic brain disease, but that we had
"some psychiatric illness" when it would be some psychiatric illness for these
lying Lyme crooks be lying their ugly faces off about us and about "Lyme
Disease," and it is psychiatry who does not have science on their
side:
Borrelia burgdorferi in the
central nervous system: experimental and clinical evidence for early invasion.
Department of
Pathology, State University of New York, Stony Brook 11794-8691.
Intravenous injection into
adult Lewis rats of live Borrelia burgdorferi, the spirochetal agent of Lyme
disease, was followed by increased permeability of the blood-brain barrier.
Permeability was measured by the ratio of 125I-labeled albumin in
cerebrospinal fluid to that in blood. Permeability changes were
dose-dependent, began 12 h after inoculation, and reversed within 1 week. Only
live, intravenously inoculated organisms produced impairment of the
blood-brain barrier. A spirochetal strain-dependent effect was noted in that
changes were more marked with a recent isolate than with a strain in long-term
in vitro culture. Mild pleocytosis and spirochetes were noted in the
cerebrospinal fluid of rats with increased blood-brain barrier permeability.
This experimental evidence for early central nervous system invasion was
pursued in studies of the human disease. Specific B. burgdorferi antigens
could be detected in the cerebrospinal fluid of patients with early Lyme
disease by use of murine monoclonal antibodies as probes.